Cd96 - CD96 antigen Gene

Also Known as Tactile; 1700109I12Rik

Species: Mus musculus

Gene Type: protein coding
Gene ID: 84544

Summary

Acts upstream of or within negative regulation of interferon-gamma production; negative regulation of natural killer cell cytokine production; and response to lipopolysaccharide. Predicted to be located in cytoplasm. Is expressed in several structures, including blood; central nervous system; ganglia; heart; and lung. Human ortholog(s) of this gene implicated in C syndrome. Orthologous to human CD96 (CD96 molecule). [provided by Alliance of Genome Resources, Apr 2022]

Cd96 Products (1)

mRNA Protein Name
NM_032465.2 NP_115854.2 T-cell surface protein tactile precursor

Gene Ontology

  • Molecular Function
  • Biological Process
Molecular Function GO Annotation Evidence References Source
enables protein binding IPI
IPI: Inferred from physical interaction
24658051 MGI
Biological Process GO Annotation Evidence References Source
acts upstream of or within cytokine production involved in inflammatory response IMP
IMP: Inferred from mutant phenotype
24658051 MGI
acts upstream of natural killer cell cytokine production IMP
IMP: Inferred from mutant phenotype
24658051 MGI
acts upstream of or within negative regulation of natural killer cell cytokine production IMP
IMP: Inferred from mutant phenotype
24658051 MGI
acts upstream of or within negative regulation of type II interferon production IMP
IMP: Inferred from mutant phenotype
24658051 MGI
acts upstream of or within response to lipopolysaccharide IMP
IMP: Inferred from mutant phenotype
24658051 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

T-cell surface protein tactile

  • T cell activation, increased late expression

  • cell surface antigen CD96

  • t cell-activated increased late expression protein

Recombinant Cd96 Proteins

Cat. No. Product Name Accession Purity
HY-P72699 CD96 Protein, Mouse (HEK293, His) Q3U0X8 (V22-M536) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (3)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0640 Epinastine 98.0% Unkown
HY-B0640A Epinastine hydrochloride 99.86% Unkown
HY-B0640AR Epinastine hydrochloride (Standard) / Unkown

Clinical Phase

Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P990053 Nelistotug Inhibitor 96.59% Phase 2

Pre-clinical Phase

Bioactive Molecules (3)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-RS02279 CD96 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS18232 Cd96 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24711 Cd96 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Inhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990259 Anti-Mouse CD96 Antibody (3.3) Inhibitor 95.00% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Cd96 NCBI NCBI:10225